Weexa Biologicals SRL
Weexa Biologicals reported total assets of 372,118 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of Weexa Biologicals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +200 % Total assets +321 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Weexa Biologicals's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
Weexa Biologicals's financial analysis
- Solvency23.7%sector median: 48.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Weexa Biologicals
Weexa Biologicals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0791.956.795
- VAT number
- BE0791956795
- Peppol
- Registered · 0208:0791956795 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Oct 2022
- Registered office
- 4122 Neupré
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Manufacture of fertilisers and nitrogen compounds (NACE 20150)
Weexa Biologicals (SRL) has been based in Neupré since 2022, active in: manufacture of fertilisers and nitrogen compounds. For 2025, it reports a net loss of 34,504 € and equity of 88,294 €; its revenue is not published. Its solvency stands at 23.7%, below the median of its sector (48.2%).
Companies similar to Weexa Biologicals
Companies in the same business, of comparable size and area, outside its group.
- Agripur Manufacture of fertilisers and nitrogen compounds Sombreffe · balance sheet 304,081 €
- Tellus Lanaken Manufacture of fertilisers and nitrogen compounds Grobbendonk · balance sheet 550,037 €
- Delixa Manufacture of fertilisers and nitrogen compounds Anzegem · balance sheet 311,698 €
- SB Agro Manufacture of fertilisers and nitrogen compounds Sombreffe · balance sheet 591,801 €
- Emexon International Manufacture of fertilisers and nitrogen compounds Diksmuide · balance sheet 305,966 €
- LP Consult Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet 304,772 €
- Stellice Business and other management consultancy activities Zaventem · balance sheet 127,463 €
- SBAM Manufacture of fertilisers and nitrogen compounds Waterloo · balance sheet 98,050 €
Frequently asked questions about Weexa Biologicals
What is the revenue of Weexa Biologicals?
Weexa Biologicals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Weexa Biologicals?
In Belgium, the VAT number is the company number prefixed with BE: BE0791956795 for Weexa Biologicals, if the company is VAT-registered. Its company number (CBE) is 0791.956.795.
Where is the registered office of Weexa Biologicals?
According to the CBE register, the registered office of Weexa Biologicals is in 4122 Neupré.
What is the equity of Weexa Biologicals?
At the close of the 2025 financial year, the equity of Weexa Biologicals amounts to 88,294 €, a solvency of 23.7% of total assets.
Who manages Weexa Biologicals?
The register lists 6 active mandates at Weexa Biologicals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Weexa Biologicals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →